ENGNW · enGene Therapeutics Inc. · Holdings

$0.18

Market Cap

$103.88M

67.02M

Volume · Oct 28 2311 Avg daily vol (3M) 13.46K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Use institutional holdings through the 13F API or MCP → See every holder of ENGNW: 13F, 13D and 13G, insiders and funds →

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.

Quarter:

Holders: 11

Total Value: $729,819

Total Shares: 2,530,328

Holder Concentration

Across 11 13F filers

Top Holder

37.6%

of institutional value

Top 5

89.9%

of institutional value

Top 10

100.0%

of institutional value

HHI

2,221

Moderately concentrated

Who Holds ENGNW

Last 1 quarters through Jun 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026: 10 filers, like-for-like change —.

Holder type	Share	Filers	Change	New
Registered adviser	21.6%	2	new	2
Exempt adviser	12.6%	1	new	1
Adviser	20.8%	1	new	1
Bank	1.3%	1	new	1
Unknown	43.8%	5	new	5

Style	Share	Filers	Change	New
Systematic-like	4.3%	1	new	1
Concentrated	59.2%	3	new	3
Diversified active	36.6%	6	new	6

Turnover	Share	Filers	Change	New
Medium turnover	68.9%	5	new	5
High turnover	31.1%	4	new	4
Unknown	0.0%	1	new	1

Holding horizon	Share	Filers	Change	New
Short horizon	34.3%	3	new	3
Medium horizon	20.6%	2	new	2
Long horizon	44.4%	4	new	4
Unknown	0.7%	1	new	1

13F book size	Share	Filers	Change	New
Under $1B	21.5%	2	new	2
$1B to $10B	60.4%	4	new	4
$10B to $100B	13.9%	3	new	3
$100B or more	4.3%	1	new	1

Client base	Share	Filers	Change	New	Exited
Pooled investment vehicles	21.6%	2	new	2	0
Unknown	78.4%	8	new	8	0

Private funds	Share	Filers	Change	New
Hedge funds	21.6%	2	new	2
Private funds, type not stated	12.6%	1	new	1
Unknown	65.8%	7	new	7

Location	Share	Filers	Change	New	Exited
United States	86.1%	8	new	8	0
Outside the US	13.9%	2	new	2	0

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

10 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders

0.000% of filers hold it in their top 10

Holders above 5%

median weight 0.001%

Crowding

—

shares outstanding is an issuer-wide count, not one listing's

Private-fund advisers

—

of shares outstanding

Institutional ownership

—

shares outstanding is an issuer-wide count, not one listing's

Top 10 holders

100.0%

of 13F shares, Herfindahl 0.233

Active holders

—

like-for-like share change of active filers

5% stakes on record

0 13D, 0 13G

How long holders have held it value-weighted 1.0 quarters

Under 1 year 100.0% 1 to 3 years 0.000% 3 years or more 0.000% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Shared Holders

Companies ENGNW's active holders also own, quarter ended Jun 30, 2026

#	Company	Shared holders	Similarity
1	STRO Sutro Biopharma, Inc.	6	0.355
2	INGN Inogen Inc	3	0.320
3	CGEM Cullinan Therapeutics, Inc.	7	0.305
4	CTMX CytomX Therapeutics, Inc.	7	0.282
5	OKUR OnKure Therapeutics, Inc.	6	0.273
6	SEER Seer, Inc.	4	0.270
7	OM Outset Medical, Inc.	4	0.270
8	BCYC Bicycle Therapeutics PLC	5	0.267
9	DMRA Damora Therapeutics, Inc.	6	0.261
10	CBIO Crescent Biopharma, Inc.	5	0.259

Shareholder Targets

13F filers that own its peers but not ENGNW, quarter ended Jun 30, 2026

Found through its holder-overlap peers: STRO, INGN, CGEM, CTMX, OKUR, SEER, OM, BCYC, DMRA, CBIO, PLRX, ARQ, RLAY, IMA, SGMT, BCAX, BCRX, FULC, TYRA, VRDN. 622 filers in all.

#	Filer	In peers	Of book	Largest peers
1	FMR LLC Holding company, Diversified active	$1,484,499,243 18 held	0.060%	RLAY, VRDN, TYRA
2	BlackRock, Inc. Holding company, Index-like	$1,306,723,437 20 held	0.020%	RLAY, BCRX, VRDN
3	RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated	$843,975,021 5 held	7.33%	TYRA, BCAX, BCRX
4	STATE STREET CORP Bank, Index-like	$780,202,313 19 held	0.020%	RLAY, BCRX, VRDN
5	VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like	$659,181,903 19 held	0.010%	RLAY, BCRX, VRDN
6	SB INVESTMENT ADVISERS (UK) LTD Registered adviser, Concentrated	$522,101,857 1 held	6.81%	RLAY
7	PRICE T ROWE ASSOCIATES INC /MD/ Registered adviser, Diversified active	$480,333,289 17 held	0.050%	RLAY, VRDN, TYRA
8	Jupiter Topco LLC Unknown, Diversified active	$389,830,941 8 held	0.160%	TYRA, BCRX, BCAX
9	GEODE CAPITAL MANAGEMENT, LLC Registered adviser, Index-like	$380,657,143 20 held	0.020%	RLAY, BCRX, VRDN
10	Fairmount Funds Management LLC Registered adviser, Concentrated	$369,607,065 3 held	24.4%	DMRA, VRDN, CBIO

Holder type: Registered adviser 3 Exempt adviser 1 Adviser 1 Bank 1 Unknown 5

Showing 11 of 11

All Common Calls Puts

Compact Export CSV

Holder

Value (USD)

% of 13F

BVF INC/IL ENGNW

$274,072

37.55%

945,402

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
BVF PARTNERS L P/IL	945,402	$274,072	100.0%	Defined

Blue Owl Capital Holdings LP ENGNW

$148,190

20.31%

511,177

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
Blue Owl Healthcare Opportunities Advisors LLC	511,177	$148,190	100.0%	Defined

Caption Management, LLC ENGNW

$96,732

13.25%

333,675

LMR Partners LLP ENGNW

$89,800

12.30%

309,763

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
LMR PARTNERS (DIFC) Ltd	309,763	$89,800	100.0%	Sole

ARISTEIA CAPITAL, L.L.C. ENGNW

$47,670

6.53%

197,678

D. E. Shaw & Co., Inc. ENGNW

$30,330

4.16%

104,622

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
D. E. SHAW & CO, L.P.	104,622	$30,330	100.0%	Defined

MILLENNIUM MANAGEMENT LLC ENGNW

$20,003

2.74%

69,000

TORONTO DOMINION BANK ENGNW

$9,148

1.25%

31,545

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
TD SECURITIES (USA) LLC	31,545	$9,147	100.0%	Defined

StoneX Group Inc. ENGNW

$8,918

1.22%

10,371

This filing is a combination report: the position is filed across the managers below.

Manager	Shares	Value (USD)	% of position	Discretion
STONEX FINANCIAL INC.	10,371	$8,918	100.0%	Defined

CSS LLC/IL ENGNW

$4,898

0.67%

16,895

Clear Street Group Inc. ENGNW

$58

0.01%

200

Key facts CIK 1980845 CUSIP 29286X101 Visit website Investor relations